サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423139

トランスフェクション技術市場レポート：製品タイプ、用途、トランスフェクション法、技術、エンドユーザー、地域別、2024年～2032年

Transfection Technologies Market Report by Product Type, Application, Transfection Method, Technology, End-User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
トランスフェクション技術市場レポート：製品タイプ、用途、トランスフェクション法、技術、エンドユーザー、地域別、2024年～2032年
出版日: 2024年01月30日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

トランスフェクション技術の世界市場規模は、2023年に11億7,200万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに22億7,530万米ドルに達し、2024年から2032年の間に7.4%の成長率（CAGR）を示すと予測しています。

トランスフェクション技術とは、デオキシリボ核酸（DNA）、リボ核酸（RNA）、オリゴヌクレオチドなどの核酸を人工的に細胞に導入するプロセスを指します。核酸は様々な物理的、化学的、生物学的方法を用いて導入され、細胞の特定の性質を変化させるのに役立ちます。コトランスフェクション、エレクトロポレーション、カチオン性脂質トランスフェクション、インビボ・トランスフェクションなど様々な方法があります。このプロセスは、遺伝子発現、スクリーニング、RNA干渉、ウイルスやタンパク質の生物学的産生を含む様々なゲノム研究に一般的に使用されています。

がんや様々な慢性生活習慣病の有病率の増加は、市場の成長を促進する主な要因の一つです。さらに、試薬ベースの方法が広く採用されていることも、市場の成長を後押ししています。従来から使用されている手法と比較すると、試薬ベースのトランスフェクションは投与の手間がかからず、費用対効果も高いです。これに伴い、バイオリスティックテクノロジー、マイクロインジェクション、レーザーフェクションなどの機器ベースの手法も、世界中で絶大な支持を得ています。細胞研究や治療法の発見におけるさまざまな技術的進歩も、成長を促す大きな要因となっています。これに伴い、遺伝子導入の研究は、新規治療薬の開発やその他の様々な応用のために、主に生体内条件下で行われています。その他の要因としては、大規模なトランスフェクション施設を開発するための政府および民間組織による投資の増加、タンパク質治療薬分野における広範な研究開発（R&D）活動などがあり、市場をさらに牽引すると予測されています。

本レポートで扱う主な質問

  • 2023年のトランスフェクション技術の世界市場規模は？
  • 2024年から2032年にかけてのトランスフェクション技術の世界市場の予想成長率は？
  • トランスフェクション技術の世界市場を牽引する主要因は何か？
  • COVID-19がトランスフェクション技術の世界市場に与えた影響は？
  • 製品タイプ別トランスフェクション技術の世界市場の内訳は？
  • トランスフェクション技術の世界市場の用途別区分は？
  • トランスフェクション法別トランスフェクション技術の世界市場内訳は？
  • 技術別トランスフェクション技術の世界市場内訳は？
  • トランスフェクション技術の世界市場における主要地域は？
  • トランスフェクション技術の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のトランスフェクション技術市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 試薬
    • 市場動向
    • 市場予測
  • 機器
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 治療デリバリー
    • 市場動向
    • 市場予測
  • バイオメディカル調査
    • 市場動向
    • 市場予測
  • タンパク質生産
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：トランスフェクション法別

  • リポフェクション
    • 市場動向
    • 市場予測
  • エレクトロポレーション
    • 市場動向
    • 市場予測
  • ヌクレオフェクション
    • 市場動向
    • 市場予測
  • コトランスフェクション
    • 市場動向
    • 市場予測
  • カチオン性脂質トランスフェクション
    • 市場動向
    • 市場予測
  • 生体内トランスフェクション
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：技術別

  • 物理的トランスフェクション
    • 市場動向
    • 市場予測
  • 生化学的トランスフェクション
    • 市場動向
    • 市場予測
  • ウイルスベクターベースのトランスフェクション
    • 市場動向
    • 市場予測

第10章 市場内訳：エンドユーザー別

  • 研究センター・学術機関
    • 市場動向
    • 市場予測
  • 病院・クリニック
    • 市場動向
    • 市場予測
  • 製薬・バイオ企業
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Bio-RAD Laboratories Inc.
    • Lonza Group AG
    • Maxcyte Inc.
    • Mirus Bio LLC
    • Polyplus Transfection
    • Promega Corporation
    • Roche Holding AG
    • Sigma-Aldrich Corporation
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Transfection Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Transfection Technologies Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Transfection Technologies Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Transfection Technologies Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Transfection Technologies Market: Breakup by Transfection Method (in %), 2023
  • Figure 6: Global: Transfection Technologies Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: Transfection Technologies Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Transfection Technologies Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Transfection Technologies (Reagent) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Transfection Technologies (Reagent) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Transfection Technologies (Instrument) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Transfection Technologies (Instrument) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Transfection Technologies (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Transfection Technologies (Therapeutic Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Transfection Technologies (Therapeutic Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Transfection Technologies (Bio-Medical Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Transfection Technologies (Bio-Medical Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Transfection Technologies (Protein Production) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Transfection Technologies (Protein Production) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Transfection Technologies (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Transfection Technologies (Lipofection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Transfection Technologies (Lipofection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Transfection Technologies (Eletroporation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Transfection Technologies (Eletroporation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Transfection Technologies (Nucleofection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Transfection Technologies (Nucleofection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Transfection Technologies (Cotransfection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Transfection Technologies (Cotransfection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Transfection Technologies (Cationic Lipid Transfection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Transfection Technologies (Cationic Lipid Transfection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Transfection Technologies (In-Vivo Transfection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Transfection Technologies (In-Vivo Transfection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Transfection Technologies (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Transfection Technologies (Physical Transfection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Transfection Technologies (Physical Transfection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Transfection Technologies (Biochemical Based Transfection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Transfection Technologies (Biochemical Based Transfection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Transfection Technologies (Viral-Vector Based Transfection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Transfection Technologies (Viral-Vector Based Transfection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Transfection Technologies (Research Centers and Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Transfection Technologies (Research Centers and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Transfection Technologies (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Transfection Technologies (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Transfection Technologies (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Transfection Technologies (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: Transfection Technologies (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: North America: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: North America: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United States: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United States: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Canada: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Canada: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Asia Pacific: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Asia Pacific: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: China: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: China: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Japan: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Japan: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: India: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: India: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: South Korea: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: South Korea: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Australia: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Australia: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Indonesia: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Indonesia: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Europe: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Europe: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Germany: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Germany: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: France: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: France: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: United Kingdom: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: United Kingdom: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Italy: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Italy: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Spain: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Spain: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Russia: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Russia: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Others: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Others: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Latin America: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Latin America: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Brazil: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Brazil: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Mexico: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Mexico: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: Others: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: Others: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 98: Middle East and Africa: Transfection Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 99: Middle East and Africa: Transfection Technologies Market: Breakup by Country (in %), 2023
  • Figure 100: Middle East and Africa: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 101: Global: Transfection Technologies Industry: SWOT Analysis
  • Figure 102: Global: Transfection Technologies Industry: Value Chain Analysis
  • Figure 103: Global: Transfection Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transfection Technologies Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transfection Technologies Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Transfection Technologies Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Transfection Technologies Market Forecast: Breakup by Transfection Method (in Million US$), 2024-2032
  • Table 5: Global: Transfection Technologies Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 6: Global: Transfection Technologies Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Transfection Technologies Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Transfection Technologies Market Structure
  • Table 9: Global: Transfection Technologies Market: Key Players
目次
Product Code: SR112024A2188

Abstract

The global transfection technologies market size reached US$ 1,172.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,275.3 Million by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.

Transfection technology refers to the process of artificially introducing nucleic acid, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the cells. It is introduced using various physical, chemical and biological methods, which can assist in modifying certain properties of the cell. It involves various methods, including cotransfection, electroporation, cationic lipid transfection and in-vivo transfection. This process is commonly used for various genomic studies that include gene expression, screening, RNA interference and Vivo research, along with the bioproduction of viruses and proteins.

The increasing prevalence of cancer and various chronic lifestyle diseases is one of the key factors driving the growth of the market. Furthermore, widespread adoption of reagent-based methods is also providing a boost to the market growth. In comparison to the traditionally used techniques, reagent-based transfection is less complicated to administer and more cost-effective. In line with this, instrument-based methods, such as biolistic technology, microinjection and laserfection, are also gaining immense traction across the globe. Various technological advancements in cell research and therapeutic discovery are acting as another major growth-inducing factor. In line with this, research in gene transfer is majorly performed under in-vivo conditions for the development of novel therapeutic drugs and various other applications. Other factors, including increasing investments by both government and private organizations to develop large scale transfection facilities, along with extensive research and development (R&D) activities in the field of protein therapeutics, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transfection technologies market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application, transfection method, technology and end-user.

Breakup by Product Type:

Reagent

Instrument

Others

Breakup by Application:

Therapeutic Delivery

Bio-Medical Research

Protein Production

Others

Breakup by Transfection Method:

Lipofection

Eletroporation

Nucleofection

Cotransfection

Cationic Lipid Transfection

In-Vivo Transfection

Others

Breakup by Technology:

Physical Transfection

Biochemical Based Transfection

Viral-Vector Based Transfection

Breakup by End-User:

Research Centers and Academic Institutes

Hospitals and Clinics

Pharmaceutical and Biotechnology Companies

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Lonza Group AG, Maxcyte Inc., Mirus Bio LLC, Polyplus Transfection, Promega Corporation, Roche Holding AG, Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report

  • 1. What was the size of the global transfection technologies market in 2023?
  • 2. What is the expected growth rate of the global transfection technologies market during 2024-2032?
  • 3. What are the key factors driving the global transfection technologies market?
  • 4. What has been the impact of COVID-19 on the global transfection technologies market?
  • 5. What is the breakup of the global transfection technologies market based on the product type?
  • 6. What is the breakup of the global transfection technologies market based on the application?
  • 7. What is the breakup of the global transfection technologies market based on the transfection method?
  • 8. What is the breakup of the global transfection technologies market based on the technology?
  • 9. What are the key regions in the global transfection technologies market?
  • 10. Who are the key players/companies in the global transfection technologies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transfection Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instrument
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutic Delivery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bio-Medical Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Protein Production
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Transfection Method

  • 8.1 Lipofection
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Eletroporation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nucleofection
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cotransfection
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Cationic Lipid Transfection
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 In-Vivo Transfection
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Physical Transfection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Based Transfection
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Viral-Vector Based Transfection
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Research Centers and Academic Institutes
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pharmaceutical and Biotechnology Companies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bio-RAD Laboratories Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Lonza Group AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Maxcyte Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Mirus Bio LLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Polyplus Transfection
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Promega Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Roche Holding AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Sigma-Aldrich Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis